|Bid||317.28 x 800|
|Ask||317.54 x 900|
|Day's Range||316.14 - 322.33|
|52 Week Range||260.03 - 335.99|
|Beta (3Y Monthly)||0.96|
|PE Ratio (TTM)||25.98|
|Earnings Date||Apr 29, 2019|
|Forward Dividend & Yield||1.20 (0.37%)|
|1y Target Est||339.33|
DaVita (DVA) is gaining steadily from expansion in international markets, strong demand in dialysis services and prudent acquisitions. However, rising expenses remain a dampener.
Chemed Corp NYSE:CHEView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low * Economic output in this company's sector is expanding Bearish sentimentShort interest | PositiveShort interest is extremely low for CHE with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting CHE. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding CHE are favorable with net inflows of $72.79 billion. This was the highest net inflow seen over the last one-year.Error parsing the SmartText Economic sentimentPMI by IHS Markit | PositiveAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Services sector is rising. The rate of growth is strong relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to email@example.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! Kevin McNamara became the CEO of Chemed Corporation (NYSE:CHE) in 2001. This report will, first, examine the CEO c...
Chemed Corporation (CHE) today announced that it will release financial results for the first quarter ended March 31, 2019, on Monday, April 29, 2019, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Tuesday, April 30, 2019, to discuss the company's quarterly results and to provide an update on its business. The toll-free dial-in number for the conference call is 844-743-2500 for U.S. and Canadian participants and +1 661-378-9533 for international participants.
Zacks.com featured expert Kevin Matras highlights: Methode Electronics, Walker & Dunlop, Marker Therapeutics, Chemed and Olympic Steel
Chemed Corporation (NYSE:CHE), which is in the healthcare business, and is based in United States, saw a significant share price rise of over 20% in the past couple of monthsRead More...
Chemed (CHE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy).
Chemed Corporation (CHE) today announced that it will deliver a presentation at the Oppenheimer 29th Annual Healthcare Conference on Tuesday, March 19, 2019, at approximately 8:35 a.m. (ET) at the Westin Grand Central Hotel in New York City. The presentation will be webcast live and can be accessed, along with the presentation materials, through the Investor Relations section of the Chemed website at www.chemed.com. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter.
Zacks.com featured expert Kevin Matras highlights: Balchem, Methode Electronics, Chemed, Ubiquiti Networks and HEXO
NEW YORK, March 04, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
Miami, FL, Feb. 28, 2019 -- Five hospice physicians employed as medical directors with VITAS® Healthcare have earned the designation Fellows of the American Academy of Hospice.
Miami, FL, Feb. 28, 2019 -- VITAS® Healthcare, the nation’s leading provider of end-of-life care, is proud to introduce its newest regional medical directors: Henri Nammour,.
Chemed Corporation (CHE) announced today that the Board of Directors has formally authorized an additional $150 million for stock repurchase under Chemed’s existing share repurchase program. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances.
Chemed Corporation (CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 30-cents per share on the Company’s capital stock, payable on March 22, 2019, to shareholders of record as of March 4, 2019. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter.